| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | USP17L21 USP17L23 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 VCPIP1 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 3.16e-18 | 114 | 198 | 19 | GO:0004843 |
| GeneOntologyMolecularFunction | deubiquitinase activity | USP17L21 USP17L23 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 VCPIP1 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.64e-17 | 124 | 198 | 19 | GO:0101005 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | USP17L21 USP17L23 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 VCPIP1 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.13e-16 | 137 | 198 | 19 | GO:0019783 |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | USP17L21 USP17L23 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 VCPIP1 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 6.31e-14 | 192 | 198 | 19 | GO:0008234 |
| GeneOntologyMolecularFunction | GTPase activator activity | ARHGAP32 MYO9B ARHGAP31 TBC1D3I TBC1D3G RASAL2 ACAP3 TBC1D3K TBC1D3F DOCK3 TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D SIPA1 TBC1D3C TBC1D3B | 3.86e-10 | 279 | 198 | 18 | GO:0005096 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | ARHGAP32 MYO9B FRMD7 ARHGEF17 PLEKHG1 ARHGAP31 TBC1D3I TBC1D3G RASAL2 ACAP3 TBC1D3K TBC1D3F DOCK3 TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D SIPA1 TBC1D3C TBC1D3B ARFGEF3 | 7.22e-09 | 507 | 198 | 22 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | ARHGAP32 MYO9B FRMD7 ARHGEF17 PLEKHG1 ARHGAP31 TBC1D3I TBC1D3G RASAL2 ACAP3 TBC1D3K TBC1D3F DOCK3 TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D SIPA1 TBC1D3C TBC1D3B ARFGEF3 | 7.22e-09 | 507 | 198 | 22 | GO:0030695 |
| GeneOntologyMolecularFunction | enzyme activator activity | EPO ARHGAP32 MYO9B ARHGAP31 TBC1D3I TBC1D3G RASAL2 ACAP3 TBC1D3K TBC1D3F DOCK3 TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D SIPA1 TBC1D3C TBC1D3B CCND3 VAC14 CBX8 | 6.45e-07 | 656 | 198 | 22 | GO:0008047 |
| GeneOntologyMolecularFunction | peptidase activity | USP17L21 RELN USP17L23 USP17L1 USP17L20 USP17L19 HM13 USP17L18 USP17L17 USP17L3 VCPIP1 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 2.34e-06 | 654 | 198 | 21 | GO:0008233 |
| GeneOntologyMolecularFunction | enzyme regulator activity | EPO ARHGAP32 MYO9B TPRN FRMD7 ARHGEF17 PPP1R26 PLEKHG1 ARHGAP31 TBC1D3I PZP TBC1D3G RASAL2 ACAP3 TBC1D3K TBC1D3F DOCK3 TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D APC SIPA1 TBC1D3C TBC1D3B PPP4R4 CCND3 ARFGEF3 VAC14 CBX8 | 2.64e-05 | 1418 | 198 | 31 | GO:0030234 |
| GeneOntologyMolecularFunction | dystroglycan binding | 1.98e-04 | 12 | 198 | 3 | GO:0002162 | |
| GeneOntologyMolecularFunction | molecular function activator activity | EPO ARHGAP32 RELN MYO9B ARHGAP31 C1QTNF4 TBC1D3I TBC1D3G RASAL2 ACAP3 TBC1D3K TBC1D3F DOCK3 TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D SIPA1 TBC1D3C TBC1D3B CCND3 VAC14 POMZP3 CBX8 | 5.32e-04 | 1233 | 198 | 25 | GO:0140677 |
| GeneOntologyMolecularFunction | actin binding | MYO9B TPRN DAG1 CLASP2 BAIAP2L1 SVIL COBL LIMA1 MYO18A TRIOBP SHROOM2 TNS4 SAMD14 | 1.03e-03 | 479 | 198 | 13 | GO:0003779 |
| GeneOntologyMolecularFunction | microtubule plus-end binding | 1.29e-03 | 22 | 198 | 3 | GO:0051010 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYO9B TPRN KIF1B DAG1 CLASP2 CCDC88B AP1AR BAIAP2L1 SVIL KIF14 COBL TRIM46 NPHS1 LIMA1 CLASP1 MYO18A APC TRIOBP SHROOM2 RMDN3 TNS4 SAMD14 | 1.37e-03 | 1099 | 198 | 22 | GO:0008092 |
| GeneOntologyBiologicalProcess | protein deubiquitination | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 VCPIP1 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.96e-16 | 125 | 197 | 18 | GO:0016579 |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 VCPIP1 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 2.55e-15 | 144 | 197 | 18 | GO:0070646 |
| GeneOntologyBiologicalProcess | activation of GTPase activity | TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B | 7.75e-09 | 109 | 197 | 11 | GO:0090630 |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | MYO9B ITGA6 TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 USP17L2 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B | 1.01e-07 | 244 | 197 | 14 | GO:0043547 |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | MYO9B ITGA6 TBC1D3I TBC1D3G PLXNA1 TBC1D3K TBC1D3F PLXNA3 TBC1D3E TBC1D3 USP17L2 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B | 1.52e-07 | 335 | 197 | 16 | GO:0043087 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | USP17L21 USP17L1 USP17L20 CUL9 USP17L19 MDM2 USP17L18 FBXO22 USP17L17 USP17L3 VCPIP1 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 MARCHF7 RFFL USP17L10 RFPL1 HDAC7 MEGF8 USP17L6P USP17L22 USP17L15 RFPL3 | 1.28e-06 | 1009 | 197 | 27 | GO:0070647 |
| GeneOntologyBiologicalProcess | post-translational protein modification | USP17L21 USP17L1 USP17L20 CUL9 USP17L19 MDM2 USP17L18 FBXO22 USP17L17 USP17L3 VCPIP1 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 MARCHF7 RFFL USP17L10 RFPL1 HDAC7 MEGF8 USP17L6P USP17L22 USP17L15 RFPL3 | 4.13e-06 | 1074 | 197 | 27 | GO:0043687 |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex disassembly | 5.28e-06 | 100 | 197 | 8 | GO:0043242 | |
| GeneOntologyBiologicalProcess | positive regulation of basement membrane assembly involved in embryonic body morphogenesis | 8.46e-06 | 5 | 197 | 3 | GO:1904261 | |
| GeneOntologyBiologicalProcess | regulation of basement membrane assembly involved in embryonic body morphogenesis | 8.46e-06 | 5 | 197 | 3 | GO:1904259 | |
| GeneOntologyBiologicalProcess | basement membrane assembly involved in embryonic body morphogenesis | 8.46e-06 | 5 | 197 | 3 | GO:2001197 | |
| GeneOntologyBiologicalProcess | protein depolymerization | 1.03e-05 | 144 | 197 | 9 | GO:0051261 | |
| GeneOntologyBiologicalProcess | regulation of hydrolase activity | MYO9B ITGA6 PPP1R26 NUAK1 TBC1D3I PZP TBC1D3G PLXNA1 TBC1D3K TBC1D3F PLXNA3 TBC1D3E TBC1D3 USP17L2 TBC1D3H TBC1D3L TBC1D3D RFFL RFPL1 TBC1D3C TBC1D3B PPP4R4 CD44 | 1.18e-05 | 878 | 197 | 23 | GO:0051336 |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | EPO ARHGAP32 RELN MYO9B FRMD7 ARHGEF17 PLEKHG1 HEG1 ARHGAP31 KIF14 DOCK3 SIPA1 ARFGEF3 | 2.02e-05 | 333 | 197 | 13 | GO:0051056 |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 2.32e-05 | 89 | 197 | 7 | GO:1901880 | |
| GeneOntologyBiologicalProcess | negative regulation of signal transduction by p53 class mediator | 4.28e-05 | 41 | 197 | 5 | GO:1901797 | |
| GeneOntologyBiologicalProcess | establishment of cell polarity | 5.30e-05 | 177 | 197 | 9 | GO:0030010 | |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 6.73e-05 | 105 | 197 | 7 | GO:1901879 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex disassembly | 7.46e-05 | 144 | 197 | 8 | GO:0043244 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | EPO DAG1 ITGA6 CLASP2 CCDC88B AP1AR AJAP1 NUAK1 GLI2 GLI3 TMEM131L KIF14 PLXNA1 PLXNA3 CLASP1 APC TRIOBP MARCHF7 RUNX1 SIPA1 POMZP3 CD44 | 8.09e-05 | 927 | 197 | 22 | GO:0030155 |
| GeneOntologyBiologicalProcess | olfactory nerve formation | 9.08e-05 | 2 | 197 | 2 | GO:0021628 | |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | MYO9B ITGA6 TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 USP17L2 TBC1D3H TBC1D3L TBC1D3D RFPL1 TBC1D3C TBC1D3B | 9.51e-05 | 499 | 197 | 15 | GO:0051345 |
| GeneOntologyBiologicalProcess | cell cycle process | TDRD9 DACH1 CUL9 MCM3 CLASP2 STOX1 PHF8 MDM2 NSFL1C SVIL MKI67 KIF14 DNA2 TOP3B TICRR CYP26B1 USP17L2 CLASP1 AHCTF1 APC XPC MEI1 RFPL1 FOXJ3 CDC14A CCND3 EIF4G1 CENPV CEP131 | 1.10e-04 | 1441 | 197 | 29 | GO:0022402 |
| GeneOntologyBiologicalProcess | regulation of basement membrane organization | 1.34e-04 | 11 | 197 | 3 | GO:0110011 | |
| GeneOntologyBiologicalProcess | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator | 1.38e-04 | 28 | 197 | 4 | GO:1902254 | |
| GeneOntologyBiologicalProcess | basement membrane assembly | 1.77e-04 | 12 | 197 | 3 | GO:0070831 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | DACH1 CUL9 STOX1 MDM2 NSFL1C SVIL MKI67 KIF14 DNA2 TICRR USP17L2 AHCTF1 APC XPC RFPL1 CDC14A CCND3 EIF4G1 CENPV CEP131 | 1.79e-04 | 845 | 197 | 20 | GO:0010564 |
| GeneOntologyBiologicalProcess | establishment or maintenance of cell polarity | MYO9B CLASP2 NSFL1C AMOTL2 WWC1 CYP26B1 CLASP1 MYO18A APC SIPA1 | 1.90e-04 | 257 | 197 | 10 | GO:0007163 |
| GeneOntologyBiologicalProcess | smoothened signaling pathway involved in ventral spinal cord interneuron specification | 2.71e-04 | 3 | 197 | 2 | GO:0021775 | |
| GeneOntologyBiologicalProcess | smoothened signaling pathway involved in spinal cord motor neuron cell fate specification | 2.71e-04 | 3 | 197 | 2 | GO:0021776 | |
| GeneOntologyBiologicalProcess | smoothened signaling pathway involved in ventral spinal cord patterning | 2.71e-04 | 3 | 197 | 2 | GO:0021910 | |
| GeneOntologyBiologicalProcess | olfactory nerve morphogenesis | 2.71e-04 | 3 | 197 | 2 | GO:0021627 | |
| GeneOntologyBiologicalProcess | positive regulation of extracellular matrix organization | 2.99e-04 | 34 | 197 | 4 | GO:1903055 | |
| GeneOntologyBiologicalProcess | neuron development | EPO ARHGAP32 RELN TPRN FRMD7 SCYL1 DAG1 ITGA6 CLASP2 PDZD7 MDM2 UNC5A NRXN3 GLI2 GLI3 MTMR2 COBL PLXNA1 ACAP3 TRIM46 PLXNA3 APC TRIOBP INPP5F RUNX1 MEGF8 CD44 SAMD14 | 3.34e-04 | 1463 | 197 | 28 | GO:0048666 |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | EPO RELN MYO9B ITGA6 STOX1 KIF14 TBC1D3I TBC1D3G TBC1D3K TBC1D3F SPATC1L TBC1D3E TBC1D3 USP17L2 TBC1D3H TBC1D3L TBC1D3D RFPL1 TBC1D3C TBC1D3B CCND3 MST1R | 3.47e-04 | 1028 | 197 | 22 | GO:0043085 |
| GeneOntologyBiologicalProcess | positive regulation of extracellular matrix assembly | 3.59e-04 | 15 | 197 | 3 | GO:1901203 | |
| GeneOntologyBiologicalProcess | embryonic body morphogenesis | 3.59e-04 | 15 | 197 | 3 | GO:0010172 | |
| GeneOntologyBiologicalProcess | proximal/distal pattern formation | 4.17e-04 | 37 | 197 | 4 | GO:0009954 | |
| GeneOntologyBiologicalProcess | microtubule depolymerization | 4.21e-04 | 66 | 197 | 5 | GO:0007019 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA damage response, signal transduction by p53 class mediator | 4.38e-04 | 16 | 197 | 3 | GO:0043518 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | EPO ARHGAP32 RELN FRMD7 ITGA6 MDM2 COBL PLXNA1 ACAP3 TRIM46 PLXNA3 TBC1D3 USP17L2 APC MARCHF7 INPP5F MEGF8 CD44 MPHOSPH9 | 4.99e-04 | 846 | 197 | 19 | GO:0120035 |
| GeneOntologyBiologicalProcess | protein-containing complex disassembly | NCKAP5 CLASP2 SVIL KIF14 CLEC16A LIMA1 CLASP1 APC TRIOBP SHROOM2 | 5.09e-04 | 291 | 197 | 10 | GO:0032984 |
| GeneOntologyBiologicalProcess | neuron projection development | EPO ARHGAP32 RELN TPRN FRMD7 DAG1 ITGA6 CLASP2 PDZD7 MDM2 UNC5A NRXN3 GLI2 GLI3 COBL PLXNA1 ACAP3 TRIM46 PLXNA3 APC TRIOBP INPP5F MEGF8 CD44 SAMD14 | 5.63e-04 | 1285 | 197 | 25 | GO:0031175 |
| GeneOntologyBiologicalProcess | negative regulation of cytoskeleton organization | 5.69e-04 | 194 | 197 | 8 | GO:0051494 | |
| GeneOntologyBiologicalProcess | negative regulation of supramolecular fiber organization | 6.30e-04 | 197 | 197 | 8 | GO:1902904 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | EPO ARHGAP32 RELN FRMD7 ITGA6 MDM2 COBL PLXNA1 ACAP3 TRIM46 PLXNA3 TBC1D3 USP17L2 APC MARCHF7 INPP5F MEGF8 CD44 MPHOSPH9 | 6.35e-04 | 863 | 197 | 19 | GO:0031344 |
| GeneOntologyBiologicalProcess | regulation of actin filament organization | FRMD7 CLASP2 AP1AR BAIAP2L1 SVIL NPHS1 LIMA1 CLASP1 TRIOBP SHROOM2 | 6.44e-04 | 300 | 197 | 10 | GO:0110053 |
| GeneOntologyBiologicalProcess | negative regulation of cellular component organization | FRMD7 CLASP2 PHF8 MDM2 SVIL MTMR2 KIF14 CLEC16A TRIM46 PLXNA3 LIMA1 CLASP1 APC TRIOBP MARCHF7 INPP5F SHROOM2 OPRD1 MPHOSPH9 | 6.44e-04 | 864 | 197 | 19 | GO:0051129 |
| GeneOntologyBiologicalProcess | regulation of intrinsic apoptotic signaling pathway by p53 class mediator | 6.80e-04 | 42 | 197 | 4 | GO:1902253 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelial sheet | 7.14e-04 | 74 | 197 | 5 | GO:0002011 | |
| Domain | HABP4_PAI-RBP1 | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 | 1.62e-21 | 16 | 191 | 12 | PF04774 |
| Domain | HABP4_PAIRBP1-bd | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 | 1.62e-21 | 16 | 191 | 12 | IPR006861 |
| Domain | UCH | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 | 4.45e-16 | 71 | 191 | 15 | PF00443 |
| Domain | USP_2 | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 | 4.45e-16 | 71 | 191 | 15 | PS00973 |
| Domain | USP_3 | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 | 5.57e-16 | 72 | 191 | 15 | PS50235 |
| Domain | USP_dom | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 | 5.57e-16 | 72 | 191 | 15 | IPR028889 |
| Domain | Peptidase_C19_UCH | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 | 5.57e-16 | 72 | 191 | 15 | IPR001394 |
| Domain | USP_CS | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 | 4.11e-15 | 66 | 191 | 14 | IPR018200 |
| Domain | USP_1 | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 | 9.91e-15 | 70 | 191 | 14 | PS00972 |
| Domain | TBC | TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B | 5.74e-11 | 49 | 191 | 10 | SM00164 |
| Domain | RabGAP-TBC | TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B | 1.32e-10 | 53 | 191 | 10 | PF00566 |
| Domain | Rab-GTPase-TBC_dom | TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B | 1.94e-10 | 55 | 191 | 10 | IPR000195 |
| Domain | TBC_RABGAP | TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B | 1.94e-10 | 55 | 191 | 10 | PS50086 |
| Domain | ARM-type_fold | SCYL1 CUL9 CLASP2 PIK3C2G DOCK3 CLASP1 NOC3L APC MEI1 PPP4R4 ARFGEF3 VAC14 EIF4G1 | 4.84e-05 | 339 | 191 | 13 | IPR016024 |
| Domain | Storkhead-box_winged-helix | 1.04e-04 | 2 | 191 | 2 | IPR019391 | |
| Domain | Stork_head | 1.04e-04 | 2 | 191 | 2 | PF10264 | |
| Domain | FHA | 1.79e-04 | 28 | 191 | 4 | SM00240 | |
| Domain | FHA_DOMAIN | 2.69e-04 | 31 | 191 | 4 | PS50006 | |
| Domain | FHA | 2.69e-04 | 31 | 191 | 4 | PF00498 | |
| Domain | Rho_GTPase_activation_prot | 2.86e-04 | 88 | 191 | 6 | IPR008936 | |
| Domain | Plexin_repeat | 3.05e-04 | 32 | 191 | 4 | IPR002165 | |
| Domain | PSI | 3.05e-04 | 32 | 191 | 4 | PF01437 | |
| Domain | - | 4.83e-04 | 36 | 191 | 4 | 2.60.200.20 | |
| Domain | FHA_dom | 4.83e-04 | 36 | 191 | 4 | IPR000253 | |
| Domain | DUF21 | 6.16e-04 | 4 | 191 | 2 | IPR002550 | |
| Domain | CLASP_N | 6.16e-04 | 4 | 191 | 2 | PF12348 | |
| Domain | CLASP_N_dom | 6.16e-04 | 4 | 191 | 2 | IPR024395 | |
| Domain | DUF21 | 6.16e-04 | 4 | 191 | 2 | PF01595 | |
| Domain | HEAT_REPEAT | 7.50e-04 | 70 | 191 | 5 | PS50077 | |
| Domain | RDM_domain_RFPL | 1.02e-03 | 5 | 191 | 2 | IPR022723 | |
| Domain | RDM | 1.02e-03 | 5 | 191 | 2 | PF11002 | |
| Domain | PSI | 1.05e-03 | 44 | 191 | 4 | IPR016201 | |
| Domain | PSI | 1.24e-03 | 46 | 191 | 4 | SM00423 | |
| Pathway | REACTOME_RAS_PROCESSING | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.48e-21 | 45 | 138 | 16 | MM15671 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L1 USP17L20 USP17L19 MDM2 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 4.91e-12 | 191 | 138 | 17 | MM15289 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 USP17L1 USP17L20 USP17L19 MDM2 USP17L18 USP17L17 USP17L3 VCPIP1 USP17L4 USP17L2 USP17L12 USP17L11 APC USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 9.60e-12 | 262 | 138 | 19 | MM15286 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L1 USP17L20 USP17L19 MDM2 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L15 | 5.07e-11 | 221 | 138 | 17 | M27578 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 USP17L1 USP17L20 USP17L19 MDM2 USP17L18 USP17L17 USP17L3 VCPIP1 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 APC USP17L5 USP17L10 USP17L22 USP17L15 | 9.50e-11 | 299 | 138 | 19 | M27574 |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 RASAL2 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 CDC14A CCND3 USP17L6P USP17L22 USP17L15 | 2.72e-10 | 318 | 138 | 19 | MM15278 |
| Pathway | WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME | TBC1D3I TBC1D3G TBC1D3K TBC1D3E TBC1D3 TBC1D3H TBC1D3L RFFL TBC1D3C TBC1D3B | 4.32e-08 | 99 | 138 | 10 | M46448 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP17L21 USP17L1 USP17L20 DAG1 USP17L19 MDM2 USP17L18 PHC3 FBXO22 POM121 USP17L17 USP17L3 VCPIP1 DPH2 SEC16B USP17L4 USP17L2 USP17L12 FBXW9 USP17L11 MUC19 APC MUC16 USP17L5 USP17L10 XPC HDAC7 USP17L6P USP17L22 USP17L15 CBX8 | 9.06e-06 | 1389 | 138 | 31 | MM15307 |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE | 1.10e-05 | 15 | 138 | 4 | MM14643 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE | 1.46e-05 | 16 | 138 | 4 | M639 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP17L21 USP17L1 USP17L20 DAG1 CUL9 USP17L19 MDM2 USP17L18 PHC3 FBXO22 POM121 USP17L17 USP17L3 VCPIP1 DPH2 SEC16B USP17L4 USP17L2 USP17L12 FBXW9 USP17L11 USP17L24 APC MUC16 USP17L5 USP17L10 XPC HDAC7 USP17L22 USP17L15 CBX8 | 2.98e-05 | 1475 | 138 | 31 | M19806 |
| Pathway | REACTOME_PI_METABOLISM | 1.06e-04 | 77 | 138 | 6 | MM14590 | |
| Pathway | REACTOME_PI_METABOLISM | 1.72e-04 | 84 | 138 | 6 | M676 | |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 2.14e-32 | 21 | 204 | 16 | 8622927 |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 2.14e-32 | 21 | 204 | 16 | 14583620 | |
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 2.14e-32 | 21 | 204 | 16 | 11468161 |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 2.14e-32 | 21 | 204 | 16 | 8756639 |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 2.14e-32 | 21 | 204 | 16 | 12447969 |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 2.14e-32 | 21 | 204 | 16 | 18980247 | |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 7.80e-32 | 22 | 204 | 16 | 9154835 | |
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 7.61e-31 | 24 | 204 | 16 | 8995226 |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 2.10e-30 | 25 | 204 | 16 | 21115691 | |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 5.44e-30 | 26 | 204 | 16 | 35816173 | |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 6.27e-30 | 33 | 204 | 17 | 20228807 | |
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.25e-29 | 34 | 204 | 17 | 14699124 |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.25e-29 | 34 | 204 | 17 | 15780755 |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.25e-29 | 34 | 204 | 17 | 17109758 | |
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.25e-29 | 34 | 204 | 17 | 20715989 |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.25e-29 | 34 | 204 | 17 | 9806828 |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.25e-29 | 34 | 204 | 17 | 20403174 | |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.25e-29 | 34 | 204 | 17 | 19188362 |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.25e-29 | 34 | 204 | 17 | 11941478 | |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.25e-29 | 34 | 204 | 17 | 20388806 | |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.25e-29 | 34 | 204 | 17 | 20368735 |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.25e-29 | 34 | 204 | 17 | 10936051 | |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.25e-29 | 34 | 204 | 17 | 21448158 | |
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 2.41e-29 | 35 | 204 | 17 | 16611142 |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 2.41e-29 | 35 | 204 | 17 | 21239494 |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 4.55e-29 | 36 | 204 | 17 | 20147298 | |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 6.84e-29 | 29 | 204 | 16 | 32527007 | |
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 8.37e-29 | 37 | 204 | 17 | 20228808 |
| Pubmed | TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12. | TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B | 2.15e-25 | 11 | 204 | 11 | 16863688 |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 4.46e-24 | 50 | 204 | 16 | 31806660 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ARHGAP32 KIF1B CLASP2 ARHGEF17 FAM53C FSIP2 PLEKHG1 STOX2 BAIAP2L1 SVIL SIK2 KIF14 COBL RASAL2 VCPIP1 LIMA1 TTC28 CLASP1 APC PTPN21 INPP5F CDC14A HDAC7 PPP4R4 EPN2 ARFGEF3 MEGF8 EIF4G1 CEP131 MPHOSPH9 CEP170B | 7.14e-16 | 861 | 204 | 31 | 36931259 |
| Pubmed | High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency. | 7.79e-12 | 10 | 204 | 6 | 24207026 | |
| Pubmed | 3.39e-11 | 12 | 204 | 6 | 24695638 | ||
| Pubmed | ES cell neural differentiation reveals a substantial number of novel ESTs. | 1.09e-10 | 14 | 204 | 6 | 11793228 | |
| Pubmed | CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1. | 9.63e-10 | 19 | 204 | 6 | 28067227 | |
| Pubmed | KIF1B CLASP2 PLEKHG1 KIF14 AMOTL2 WWC1 RASAL2 LIMA1 TTC28 CLASP1 APC KIAA1549 INPP5F HDAC7 CEP131 MPHOSPH9 CEP170B | 1.47e-09 | 446 | 204 | 17 | 24255178 | |
| Pubmed | KIF1B CUL9 PHF8 ARHGEF17 PLEKHH1 UNC5A PLEKHG1 COBL CLEC16A VCPIP1 TTC28 CLASP1 IGDCC4 ARFGEF3 MEGF8 CEP170B | 2.94e-09 | 407 | 204 | 16 | 12693553 | |
| Pubmed | USP17L21 USP17L1 NHSL2 USP17L20 IRF2 USP17L19 USP17L18 USP17L17 USP17L3 DOCK3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 TMEM132D USP17L6P USP17L22 USP17L15 | 3.73e-09 | 674 | 204 | 20 | 37196079 | |
| Pubmed | CLASP2 BAIAP2L1 COBL WWC1 RASAL2 VCPIP1 TTC28 CLASP1 APC ARFGEF3 CEP131 CEP170B | 4.59e-09 | 209 | 204 | 12 | 36779422 | |
| Pubmed | ARHGAP32 STOX2 POM121 GLI3 SVIL MKI67 TMEM131L RASAL2 VCPIP1 TTC28 AHCTF1 APC KIAA1549 | 6.29e-09 | 263 | 204 | 13 | 34702444 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | KMT2B MYO9B CUL9 CLASP2 ANKHD1 PPP1R26 PLEKHG1 HEG1 NUAK1 COBL TOP3B PLXNA1 DOCK3 PLXNA3 DPH2 FBRSL1 HDAC7 CCND3 MST1R VAC14 MEGF8 EIF4G1 CENPV CEP131 CEP170B | 9.28e-09 | 1105 | 204 | 25 | 35748872 |
| Pubmed | DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. | TBC1D3G TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3D MYO18A TBC1D3B | 1.32e-08 | 74 | 204 | 8 | 16625196 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | MYO9B TPRN KIF1B BCORL1 CUL9 MCM3 MDM2 BAIAP2L1 TONSL KIF14 VCPIP1 TTC28 CLASP1 FBRSL1 APC ARFGEF3 CEP131 CEP170B | 1.45e-08 | 588 | 204 | 18 | 38580884 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | KMT2B ZC3H13 KIF1B MCM3 PHF8 FAM53C PHC3 NSFL1C SVIL MKI67 VCPIP1 SEC16B LIMA1 CLASP1 MYO18A RFFL XPC RUNX1 HDAC7 EIF4G1 | 3.70e-08 | 774 | 204 | 20 | 15302935 |
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | USP17L21 USP17L20 USP17L19 USP17L18 NUAK1 USP17L17 USP17L12 PCDHGC4 USP17L11 | 3.82e-08 | 119 | 204 | 9 | 28625976 |
| Pubmed | KIF1B SCYL1 MCM3 CLASP2 SNAP47 BAIAP2L1 GLI3 MKI67 CLEC16A RASAL2 TTC28 NOC3L APC MUC16 ABCC5 ARFGEF3 CD44 CEP131 MPHOSPH9 | 1.92e-07 | 777 | 204 | 19 | 35844135 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | ARHGAP32 KIF1B MCM3 PHF8 PLEKHG1 NSFL1C BAIAP2L1 SVIL MTMR2 KIF14 COBL CLEC16A VCPIP1 TTC28 NOC3L APC MPHOSPH9 CEP170B CBX8 | 7.84e-07 | 853 | 204 | 19 | 28718761 |
| Pubmed | PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer. | 7.92e-07 | 4 | 204 | 3 | 12359748 | |
| Pubmed | 7.92e-07 | 4 | 204 | 3 | 8406013 | ||
| Pubmed | 8.47e-07 | 87 | 204 | 7 | 17979178 | ||
| Pubmed | 1.10e-06 | 14 | 204 | 4 | 19783738 | ||
| Pubmed | ARHGAP32 TPRN ITGA6 CLASP2 PHF8 SVIL MKI67 MTMR2 KIF14 TOP3B NOC3L TRIOBP KIAA1549 PTPN21 CDC14A PPP4R4 CNNM4 CD44 CEP131 MPHOSPH9 CBX8 | 1.12e-06 | 1049 | 204 | 21 | 27880917 | |
| Pubmed | Regulation of the Mdm2-p53 pathway by the ubiquitin E3 ligase MARCH7. | 1.49e-06 | 15 | 204 | 4 | 29295817 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | ARHGAP32 INPP5D SCYL1 MDM2 PHC3 POM121 BAIAP2L1 ARHGAP31 GLI2 TONSL DOCK3 FOXJ3 TSHZ1 | 1.80e-06 | 430 | 204 | 13 | 35044719 |
| Pubmed | 1.97e-06 | 5 | 204 | 3 | 12604796 | ||
| Pubmed | 1.97e-06 | 5 | 204 | 3 | 23940118 | ||
| Pubmed | Role of CLASP2 in microtubule stabilization and the regulation of persistent motility. | 1.97e-06 | 5 | 204 | 3 | 17113391 | |
| Pubmed | 1.97e-06 | 5 | 204 | 3 | 8471161 | ||
| Pubmed | 2.83e-06 | 104 | 204 | 7 | 10470851 | ||
| Pubmed | KIF1B BAIAP2L1 SVIL RASAL2 LIMA1 CLASP1 SHROOM2 HDAC7 EPN2 RMDN3 | 2.98e-06 | 255 | 204 | 10 | 15324660 | |
| Pubmed | ANKHD1 STOX2 NRXN3 NUAK1 ARHGAP31 TMEM131L AMOTL2 DNA2 ACAP3 FBRSL1 TRIOBP KIAA1549 INPP5F FOXJ3 | 3.37e-06 | 529 | 204 | 14 | 14621295 | |
| Pubmed | ARHGAP32 KIF1B CLASP2 MDH2 ARHGEF17 SNAP47 NDUFV1 SVIL MTMR2 RASAL2 TRIM46 SLC12A6 LIMA1 CLASP1 PRR36 MYO18A APC KIAA1549 SIPA1 GRM2 SHROOM2 EPN2 EIF4G1 CEP170B | 4.03e-06 | 1431 | 204 | 24 | 37142655 | |
| Pubmed | 4.16e-06 | 19 | 204 | 4 | 32234482 | ||
| Pubmed | APC sets the Wnt tone necessary for cerebral cortical progenitor development. | 4.16e-06 | 19 | 204 | 4 | 28916710 | |
| Pubmed | Specific requirement of Gli transcription factors in Hedgehog-mediated intestinal development. | 4.16e-06 | 19 | 204 | 4 | 23645682 | |
| Pubmed | ARHGAP32 NHSL2 MCM3 CLASP2 STOX2 SVIL TOP3B RASAL2 TRIM46 LIMA1 CLASP1 PRR36 APC TRIOBP SIPA1 GRM2 EIF4G1 CEP131 CEP170B | 4.58e-06 | 963 | 204 | 19 | 28671696 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | ARHGAP32 MYO9B MDM2 MTMR2 PLXNA3 TBC1D3H ZNF652 MUC16 ABCC5 CCND3 ARFGEF3 CD44 TNS4 TINCR | 5.48e-06 | 552 | 204 | 14 | 10737800 |
| Pubmed | DAG1 CUL9 MDM2 NUAK1 SVIL MKI67 AMOTL2 TTC28 NOC3L MYO18A XPC RUNX1 SIPA1 CCND3 CBX8 | 5.81e-06 | 634 | 204 | 15 | 34591612 | |
| Pubmed | 6.36e-06 | 21 | 204 | 4 | 22935613 | ||
| Pubmed | 6.84e-06 | 7 | 204 | 3 | 28799057 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | ARHGAP32 FRMD7 DAG1 ITGA6 AP1AR BAIAP2L1 ARHGAP31 COBL PLXNA1 RASAL2 KIAA1549 ABCC5 EPN2 CD44 | 7.72e-06 | 569 | 204 | 14 | 30639242 |
| Pubmed | 8.52e-06 | 81 | 204 | 6 | 12838346 | ||
| Pubmed | ZC3H13 ANKHD1 CCDC88B QRICH2 AP1AR SIK2 TMEM131L PLXNA1 TBC1D3F SPATC1L VCPIP1 PDZRN4 LIMA1 TBC1D3 TBC1D3D POLI | 1.03e-05 | 750 | 204 | 16 | 11230166 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 1.41e-05 | 184 | 204 | 8 | 32908313 | |
| Pubmed | 1.55e-05 | 26 | 204 | 4 | 26387942 | ||
| Pubmed | Loss of the collagen IV modifier prolyl 3-hydroxylase 2 causes thin basement membrane nephropathy. | 1.63e-05 | 9 | 204 | 3 | 35499085 | |
| Pubmed | Gli3 null mice display glandular overgrowth of the developing stomach. | 1.63e-05 | 9 | 204 | 3 | 16247775 | |
| Pubmed | ARHGAP32 HM13 PLEKHG1 KIF14 TRIOBP ARFGEF3 CEP131 MPHOSPH9 CEP170B | 1.91e-05 | 251 | 204 | 9 | 29778605 | |
| Pubmed | Novel interactors and a role for supervillin in early cytokinesis. | 2.11e-05 | 28 | 204 | 4 | 20309963 | |
| Pubmed | 2.16e-05 | 57 | 204 | 5 | 29089450 | ||
| Pubmed | 2.31e-05 | 10 | 204 | 3 | 38358805 | ||
| Pubmed | 2.31e-05 | 10 | 204 | 3 | 23001180 | ||
| Pubmed | Direct and indirect requirements of Shh/Gli signaling in early pituitary development. | 2.43e-05 | 29 | 204 | 4 | 20934421 | |
| Pubmed | RELN KIF1B CUL9 NCKAP5 FAM53C PLEKHH1 MTMR2 AMOTL2 RASAL2 SPATC1L VCPIP1 DOCK3 TTC28 APC TRIOBP ZNF343 ABCC5 XPC RUNX1 SHROOM2 EIF4G1 | 2.46e-05 | 1285 | 204 | 21 | 35914814 | |
| Pubmed | 2.79e-05 | 30 | 204 | 4 | 24073291 | ||
| Pubmed | 3.19e-05 | 102 | 204 | 6 | 9734811 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | KMT2B ZC3H13 BCORL1 STOX1 PHF8 ARHGEF17 QRICH2 IGSF10 USP17L3 AMOTL2 IPPK TICRR CYP26B1 USP17L12 MUC19 | 3.31e-05 | 736 | 204 | 15 | 29676528 |
| Pubmed | ARHGAP32 NCKAP5 CCDC88B FAM53C POM121 ARHGAP31 COBL TBC1D3F MYO18A APC RMDN3 MPHOSPH9 | 3.37e-05 | 486 | 204 | 12 | 20936779 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 16914514 | ||
| Pubmed | DACH1 suppresses breast cancer as a negative regulator of CD44. | 3.42e-05 | 2 | 204 | 2 | 28659634 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 17283082 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 20154143 | ||
| Pubmed | Ki-67 regulates global gene expression and promotes sequential stages of carcinogenesis. | 3.42e-05 | 2 | 204 | 2 | 33658388 | |
| Pubmed | Human CLASP1 is an outer kinetochore component that regulates spindle microtubule dynamics. | 3.42e-05 | 2 | 204 | 2 | 12837247 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 31980982 | ||
| Pubmed | In vitro study on the effect of doxorubicin on the proliferation markers MCM3 and Ki-67. | 3.42e-05 | 2 | 204 | 2 | 24344040 | |
| Pubmed | Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis. | 3.42e-05 | 2 | 204 | 2 | 27617574 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 38149326 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 24706765 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 32567731 | ||
| Interaction | YWHAH interactions | ARHGAP32 NHSL2 ZC3H13 KIF1B CLASP2 ARHGEF17 FAM53C PLEKHG1 STOX2 NUAK1 BAIAP2L1 SVIL SIK2 KIF14 COBL AMOTL2 CLEC16A WWC1 RASAL2 VCPIP1 TICRR LIMA1 TTC28 CLASP1 APC PTPN21 INPP5F SIPA1 CDC14A HDAC7 PPP4R4 EPN2 ARFGEF3 MST1R RMDN3 MEGF8 EIF4G1 CEP131 MPHOSPH9 CEP170B | 2.52e-13 | 1102 | 194 | 40 | int:YWHAH |
| Interaction | YWHAG interactions | ARHGAP32 NHSL2 ZC3H13 KIF1B MCM3 CLASP2 ARHGEF17 FAM53C PLEKHG1 STOX2 NUAK1 BAIAP2L1 SVIL SIK2 KIF14 COBL AMOTL2 WWC1 RASAL2 TICRR LIMA1 TTC28 CLASP1 APC PTPN21 INPP5F SIPA1 SHROOM2 CDC14A HDAC7 PPP4R4 EPN2 MST1R RMDN3 EIF4G1 CEP131 MPHOSPH9 CEP170B | 1.99e-10 | 1248 | 194 | 38 | int:YWHAG |
| Interaction | SFN interactions | ARHGAP32 KIF1B CLASP2 MDM2 ARHGEF17 FAM53C STOX2 NSFL1C SVIL SIK2 KIF14 COBL CCR1 RASAL2 VCPIP1 LIMA1 CLASP1 APC INPP5F HDAC7 PPP4R4 MST1R EIF4G1 CEP131 MPHOSPH9 TNS4 CEP170B | 6.47e-10 | 692 | 194 | 27 | int:SFN |
| Interaction | YWHAB interactions | ARHGAP32 KIF1B CLASP2 ARHGEF17 FAM53C STOX2 NUAK1 BAIAP2L1 SVIL SIK2 KIF14 AMOTL2 WWC1 RASAL2 TICRR LIMA1 TTC28 CLASP1 APC PTPN21 INPP5F SIPA1 CDC14A HDAC7 PPP4R4 EPN2 MST1R RMDN3 EIF4G1 CEP131 MPHOSPH9 CEP170B | 2.85e-09 | 1014 | 194 | 32 | int:YWHAB |
| Interaction | YWHAQ interactions | ARHGAP32 ZC3H13 KIF1B MCM3 CLASP2 MDM2 FAM53C STOX2 SVIL SIK2 KIF14 AMOTL2 WWC1 RASAL2 TICRR LIMA1 TTC28 CLASP1 APC INPP5F SIPA1 GRM2 CDC14A HDAC7 PPP4R4 EPN2 MST1R RMDN3 EIF4G1 CEP131 MPHOSPH9 CEP170B | 2.90e-08 | 1118 | 194 | 32 | int:YWHAQ |
| Interaction | SFTPC interactions | CNNM2 DAG1 ITGA6 PHC3 CILP2 POM121 TMEM131L PLXNA1 PLXNA3 MST1R CNNM4 MEGF8 CBX8 | 2.51e-07 | 222 | 194 | 13 | int:SFTPC |
| Interaction | PPP1CB interactions | TPRN DAG1 MCM3 NUAK1 SVIL SIK2 KIF14 COBL CLEC16A SPATC1L LIMA1 MYO18A TRIOBP SIPA1 HDAC7 CCND3 PPP1R3A EIF4G1 | 7.04e-07 | 469 | 194 | 18 | int:PPP1CB |
| Interaction | YWHAE interactions | ARHGAP32 KIF1B CLASP2 FAM53C STOX2 NUAK1 BAIAP2L1 SVIL MTMR2 SIK2 KIF14 AMOTL2 WWC1 RASAL2 TBC1D3F TICRR LIMA1 TTC28 CLASP1 APC PTPN21 INPP5F SHROOM2 CDC14A HDAC7 PPP4R4 MST1R RMDN3 CEP131 MPHOSPH9 CEP170B | 1.25e-06 | 1256 | 194 | 31 | int:YWHAE |
| Interaction | MAPRE3 interactions | MYO9B KIF1B NCKAP5 CLASP2 KIF14 COBL TTC28 CLASP1 APC MARCHF7 CEP131 CEP170B | 2.48e-06 | 230 | 194 | 12 | int:MAPRE3 |
| Interaction | YWHAZ interactions | ARHGAP32 KIF1B CLASP2 MDH2 MDM2 FAM53C FSIP2 STOX2 BAIAP2L1 SVIL SIK2 KIF14 RASAL2 TICRR LIMA1 TTC28 CLASP1 MYO18A APC PTPN21 INPP5F SIPA1 CDC14A HDAC7 PPP4R4 EPN2 MST1R RMDN3 CEP131 MPHOSPH9 CEP170B | 3.44e-06 | 1319 | 194 | 31 | int:YWHAZ |
| Interaction | RHOQ interactions | ARHGAP32 DAG1 ITGA6 SNAP47 PLEKHG1 BAIAP2L1 KIF14 RASAL2 MYO18A TRIOBP KIAA1549 ABCC5 INPP5F ARFGEF3 VAC14 CD44 | 6.29e-06 | 442 | 194 | 16 | int:RHOQ |
| Interaction | TOP3B interactions | KMT2B MYO9B KIF1B CUL9 CLASP2 ANKHD1 PPP1R26 PLEKHG1 HEG1 FBXO22 NUAK1 SVIL KIF14 COBL DNA2 TOP3B PLXNA1 DOCK3 PLXNA3 DPH2 LIMA1 FBRSL1 CDC14A HDAC7 CCND3 MST1R VAC14 MEGF8 EIF4G1 CENPV CEP131 CEP170B | 1.14e-05 | 1470 | 194 | 32 | int:TOP3B |
| Interaction | BTNL2 interactions | 1.98e-05 | 155 | 194 | 9 | int:BTNL2 | |
| Interaction | VPS33B interactions | KIF1B HM13 PLEKHG1 KIF14 RFFL ARFGEF3 RMDN3 CEP131 MPHOSPH9 CEP170B | 2.40e-05 | 199 | 194 | 10 | int:VPS33B |
| Interaction | LATS2 interactions | MDM2 PLEKHG1 FBXO22 AMOTL2 TOP3B WWC1 RASAL2 APC KIAA1549 CD44 CEP131 MPHOSPH9 | 2.49e-05 | 289 | 194 | 12 | int:LATS2 |
| Interaction | PPP1CA interactions | TPRN MCM3 MDM2 PPP1R26 FBXO22 GLI3 MKI67 SIK2 KIF14 CLEC16A LIMA1 AHCTF1 MYO18A APC TRIOBP CCND3 PPP1R3A ARFGEF3 MST1R | 4.52e-05 | 696 | 194 | 19 | int:PPP1CA |
| Interaction | NIN interactions | MCM3 CLASP2 PLEKHG1 SVIL KIF14 VCPIP1 TTC28 CLASP1 APC CDC14A ARFGEF3 CEP131 CEP170B | 4.74e-05 | 359 | 194 | 13 | int:NIN |
| Interaction | IQGAP1 interactions | TPRN SCYL1 ARHGEF17 SVIL SIK2 KIF14 COBL TOP3B NPHS1 LIMA1 MYO18A APC TRIOBP SIPA1 MST1R EIF4G1 CD44 | 6.11e-05 | 591 | 194 | 17 | int:IQGAP1 |
| Interaction | RNF43 interactions | ARHGAP32 STOX2 POM121 GLI3 SVIL MKI67 TMEM131L TOP3B RASAL2 VCPIP1 TTC28 AHCTF1 APC KIAA1549 | 7.09e-05 | 427 | 194 | 14 | int:RNF43 |
| Interaction | GOLGA1 interactions | PLEKHG1 AP1AR FBXO22 TTC28 APC ARFGEF3 CEP131 MPHOSPH9 CEP170B | 7.26e-05 | 183 | 194 | 9 | int:GOLGA1 |
| Interaction | LIMA1 interactions | TPRN FAM53C SVIL MKI67 SIK2 KIF14 COBL TOP3B RASAL2 LIMA1 MYO18A SIPA1 HDAC7 CD44 | 7.45e-05 | 429 | 194 | 14 | int:LIMA1 |
| Interaction | TRIM36 interactions | 7.86e-05 | 144 | 194 | 8 | int:TRIM36 | |
| Interaction | RHOA interactions | ARHGAP32 MYO9B DAG1 ITGA6 HM13 MDM2 ARHGEF17 SNAP47 NDUFV1 NSFL1C BAIAP2L1 ARHGAP31 MKI67 KIF14 CCR1 CLEC16A TOP3B PLXNA1 RASAL2 LIMA1 MYO18A KIAA1549 ABCC5 SIPA1 HDAC7 CD44 | 8.86e-05 | 1199 | 194 | 26 | int:RHOA |
| Interaction | LGALS1 interactions | DAG1 ITGA6 HEG1 KIF14 PLXNA1 SLC12A6 LIMA1 KIAA1549 MUC16 IGDCC4 CNNM4 CD44 | 9.47e-05 | 332 | 194 | 12 | int:LGALS1 |
| Interaction | GSK3B interactions | MCM3 CLASP2 MDH2 MDM2 NSFL1C BAIAP2L1 TONSL MKI67 COBL WWC1 RASAL2 VCPIP1 TTC28 CLASP1 APC TRIOBP ARFGEF3 EIF4G1 CENPV CEP131 CEP170B | 1.00e-04 | 868 | 194 | 21 | int:GSK3B |
| Interaction | SYNPO interactions | 1.05e-04 | 192 | 194 | 9 | int:SYNPO | |
| Interaction | TPRN interactions | 1.06e-04 | 49 | 194 | 5 | int:TPRN | |
| Interaction | COBL interactions | 1.06e-04 | 78 | 194 | 6 | int:COBL | |
| Interaction | MYO1C interactions | TPRN SVIL KIF14 COBL CLEC16A TOP3B WWC1 LIMA1 CLASP1 MYO18A TRIOBP SIPA1 GRM2 | 1.30e-04 | 397 | 194 | 13 | int:MYO1C |
| Interaction | LZTS2 interactions | ARHGAP32 HM13 MDM2 PLEKHG1 KIF14 CLEC16A SPATC1L TTC28 MYO18A FBRSL1 APC SIPA1 CEP131 MPHOSPH9 CBX8 | 1.37e-04 | 512 | 194 | 15 | int:LZTS2 |
| Interaction | NPAS1 interactions | 1.37e-04 | 245 | 194 | 10 | int:NPAS1 | |
| Interaction | RAB35 interactions | ARHGAP32 DAG1 ITGA6 HM13 SNAP47 BAIAP2L1 KIF14 PLXNA1 RASAL2 SLC12A6 APC KIAA1549 ABCC5 INPP5F ARFGEF3 CNNM4 | 1.42e-04 | 573 | 194 | 16 | int:RAB35 |
| Interaction | GSK3A interactions | CLASP2 BAIAP2L1 GLI3 COBL WWC1 RASAL2 VCPIP1 TTC28 CLASP1 APC RUNX1 ARFGEF3 CEP131 CEP170B | 1.69e-04 | 464 | 194 | 14 | int:GSK3A |
| Interaction | CRTC3 interactions | 1.85e-04 | 55 | 194 | 5 | int:CRTC3 | |
| Cytoband | 4p16.1 | USP17L21 USP17L23 USP17L20 USP17L19 USP17L18 USP17L17 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 7.19e-19 | 79 | 204 | 14 | 4p16.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | USP17L21 USP17L23 USP17L20 USP17L19 USP17L18 USP17L17 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.77e-12 | 222 | 204 | 14 | chr4p16 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D RFFL TBC1D3C TBC1D3B | 3.98e-12 | 149 | 204 | 12 | chr17q12 |
| Cytoband | 17q12 | 5.68e-06 | 99 | 204 | 6 | 17q12 | |
| Cytoband | 7q34 | 9.39e-04 | 167 | 204 | 5 | 7q34 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.96e-04 | 181 | 119 | 7 | 694 | |
| GeneFamily | Phosphoinositide phosphatases | 1.20e-03 | 32 | 119 | 3 | 1079 | |
| GeneFamily | Plexins | 1.50e-03 | 9 | 119 | 2 | 683 | |
| Coexpression | MADAN_DPPA4_TARGETS | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 PLEKHG1 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.07e-19 | 86 | 198 | 17 | MM1312 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 ABCD4 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.21e-17 | 112 | 198 | 17 | MM1095 |
| Coexpression | GERY_CEBP_TARGETS | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 WWC1 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 5.67e-15 | 160 | 198 | 17 | MM1155 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | USP17L21 USP17L1 USP17L20 INPP5D ITGA6 USP17L19 MDM2 USP17L18 POM121 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.15e-07 | 647 | 198 | 20 | MM981 |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | USP17L21 USP17L1 USP17L20 MCM3 IRF2 USP17L19 MDM2 USP17L18 NSFL1C USP17L17 USP17L3 CCR1 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 FOXJ3 CCND3 USP17L6P TSHZ1 USP17L22 USP17L15 | 2.09e-06 | 1072 | 198 | 24 | MM1031 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA | RELN PDZD7 STOX2 NRXN3 AJAP1 COBL PDZRN4 TRIM46 PLXNA3 TBC1D3 PCDHGC4 MUC19 MUC16 SHROOM2 SAMD14 | 7.76e-06 | 506 | 198 | 15 | M39067 |
| Coexpression | GSE17721_CTRL_VS_LPS_4H_BMDC_UP | 2.27e-05 | 200 | 198 | 9 | M3689 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | MYO9B ITGA6 CLASP2 PHF8 HEG1 NUAK1 TMEM131L KIF14 CLEC16A WWC1 TTC28 CLASP1 AHCTF1 APC MARCHF7 INPP5F RUNX1 FOXJ3 MPHOSPH9 | 2.89e-05 | 856 | 198 | 19 | M4500 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | CNNM2 INPP5D DACH1 ITGA6 STOX1 PHF8 HSD11B1L ARHGEF17 TUB PLEKHG1 GLI3 TBC1D3G TOP3B TBC1D3K TBC1D3F DOCK3 TBC1D3 TBC1D3H TBC1D3L PCDHGC4 TTC28 TBC1D3D PRR36 TBC1D3C TBC1D3B IGDCC4 BARHL1 POLI SAMD14 TINCR | 1.54e-08 | 1075 | 185 | 30 | PCBC_ratio_ECTO_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05 | TBC1D3G TBC1D3K TBC1D3F TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B | 9.16e-08 | 90 | 185 | 9 | PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | DACH1 STOX1 PHF8 HSD11B1L ARHGEF17 PLEKHG1 NUAK1 GLI3 SVIL SIK2 AMOTL2 TBC1D3G CLEC16A TOP3B PLXNA1 TBC1D3K TBC1D3F DOCK3 PLXNA3 TBC1D3 TBC1D3H TBC1D3L PCDHGC4 TTC28 TBC1D3D PTPN21 TBC1D3C TBC1D3B IGDCC4 BARHL1 POLI SAMD14 TINCR | 4.30e-07 | 1466 | 185 | 33 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | SVIL TONSL TBC1D3G TBC1D3K TBC1D3F TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B IGDCC4 | 6.98e-06 | 281 | 185 | 12 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | SVIL TONSL TBC1D3G TBC1D3K TBC1D3F TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B IGDCC4 | 6.98e-06 | 281 | 185 | 12 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | RELN TBC1D3G TBC1D3K TBC1D3F TBC1D3 TBC1D3H TBC1D3L PGGHG TBC1D3D TBC1D3C TBC1D3B IGDCC4 | 2.55e-05 | 320 | 185 | 12 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | DE cord blood_vs_DE blastocyst-Confounder_removed-fold2.0_adjp0.05 | TBC1D3G TBC1D3K TBC1D3F TBC1D3 TBC1D3H TBC1D3L PGGHG TBC1D3D TBC1D3C TBC1D3B | 5.44e-05 | 242 | 185 | 10 | PCBC_ratio_DE cord blood_vs_DE blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3G TBC1D3K TBC1D3F TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B | 1.09e-04 | 213 | 185 | 9 | PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3G TBC1D3K TBC1D3F TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B | 1.09e-04 | 213 | 185 | 9 | PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | EPO RELN ZC3H13 DACH1 NCKAP5 STOX2 HEG1 GLI3 MKI67 TMEM131L KIF14 DNA2 RASAL2 TICRR CLASP1 PRR36 APC KIAA1549 USP17L10 CDC14A GPATCH3 SAMD14 | 1.45e-04 | 1060 | 185 | 22 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.64e-04 | 225 | 185 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | EPO RELN ZC3H13 DACH1 NCKAP5 UNC5A STOX2 HEG1 NRXN3 GLI3 MKI67 TMEM131L KIF14 DNA2 RASAL2 DOCK3 TICRR CLASP1 PRR36 APC KIAA1549 USP17L10 CDC14A GPATCH3 TNS4 SAMD14 | 2.45e-04 | 1414 | 185 | 26 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-06 | 180 | 195 | 8 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 | |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-06 | 180 | 195 | 8 | 423454e3390080ae03bb3cbb267255ebfe4df080 | |
| ToppCell | COVID-19-Heart-EC_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.51e-06 | 183 | 195 | 8 | ff95382cfed592190d0636d2b750328471f82e0d | |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.92e-06 | 189 | 195 | 8 | bccb3481ffed597c845fe860da658505316105b5 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-06 | 190 | 195 | 8 | a08c5929b05a4969852e351a93c4e4deb4c8d5b6 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-06 | 190 | 195 | 8 | 25525fee1da8a808034d9c916159fd0b6b26bce8 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 2.00e-06 | 190 | 195 | 8 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-06 | 191 | 195 | 8 | f663131a4810584c5854bd64ee7991a237b7707f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-06 | 191 | 195 | 8 | 9032aa974aa1b7b1095b8d1b58dcb087358a5001 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-06 | 191 | 195 | 8 | 5717809a1476c20f65bce722c5a57cff92ee0d7a | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-06 | 193 | 195 | 8 | 826b8dd801298b3e0cd76232feae5a14026b8806 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-06 | 193 | 195 | 8 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-06 | 193 | 195 | 8 | 87d3a577d37fb0cb4b6313c596310de452bc3872 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-06 | 193 | 195 | 8 | d485634c564b268e344b6a2863c26f6adaec9e38 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 2.72e-06 | 139 | 195 | 7 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.92e-06 | 200 | 195 | 8 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.92e-06 | 200 | 195 | 8 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.92e-06 | 200 | 195 | 8 | 85c0f038bcfb42669dca2b80273b0f8a1421405e | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epi_progenitor|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.58e-06 | 155 | 195 | 7 | be575a0096415705dba425002247289ff8f89474 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.74e-06 | 166 | 195 | 7 | 9d4b44eb56ad38c26aed73444edf389abca6bdf6 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.06e-05 | 171 | 195 | 7 | 1ae4b6a25bc9c1065cf5d95998ebcc70aee21ab5 | |
| ToppCell | facs-Heart-LV-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 172 | 195 | 7 | f2c17c49b375b28ad47dc6cabda62f1c238023dd | |
| ToppCell | facs-Heart-LV-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 172 | 195 | 7 | 6ab4f01098dddb789df298ddf97b3c384405ee6c | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.10e-05 | 172 | 195 | 7 | 7c238a7375341d4647ba7274d93fddfb6fae7ce4 | |
| ToppCell | Control-Endothelial_cells-Capillary_endothelial_cells|Control / group, cell type (main and fine annotations) | 1.48e-05 | 180 | 195 | 7 | b043f9ffb9a4cd427a15bebb86a711c7b08866e8 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 180 | 195 | 7 | 6ac62bf1251978c8c12e715f7b73144fca619794 | |
| ToppCell | droplet-Lung-nan-21m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-05 | 182 | 195 | 7 | 40539ade8c3cd12b61f1cd0d493828e58282796b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-05 | 184 | 195 | 7 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 1.77e-05 | 185 | 195 | 7 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-05 | 187 | 195 | 7 | 35c382c0aabd46906113e5db30ea24bb8e658899 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-05 | 188 | 195 | 7 | 0aa8747c2931b0c91f6d78bb2db8fd8ede6dd559 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.96e-05 | 188 | 195 | 7 | 0026c9479b30fb39daa91cfa220a88f9c9e65fe7 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D122|Adult / Lineage, Cell type, age group and donor | 1.96e-05 | 188 | 195 | 7 | 02a62888e9db29d20133eeca1686d302545a39c9 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.03e-05 | 189 | 195 | 7 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.10e-05 | 190 | 195 | 7 | 625c08a0e5227efc46daa512fd579c3938ff76c7 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-05 | 191 | 195 | 7 | c06bbad24e4897b2c3b5015e4de02411ebf75367 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.17e-05 | 191 | 195 | 7 | 23776c7302cead3881b39127398f3b3e0d27885e | |
| ToppCell | facs-Lung-nan-3m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-05 | 191 | 195 | 7 | 5f43f98cfe7a08d61ed55f34808fabfe47f1ac2e | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.24e-05 | 192 | 195 | 7 | 8899d81306770adda893b5e146df1253971754c5 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.24e-05 | 192 | 195 | 7 | 5fda9a465c9f77c7fa1a3ea07a2b0374bbc23b2a | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 2.32e-05 | 193 | 195 | 7 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.32e-05 | 193 | 195 | 7 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 2.32e-05 | 193 | 195 | 7 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-05 | 193 | 195 | 7 | 263d185af6ed80e639f864e4966268e0862c61dc | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-05 | 193 | 195 | 7 | 80e058c224749b5fe0ba3e944b48317c2371cb63 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-05 | 193 | 195 | 7 | b991fbbb4618401624f0b3045f0e81a606d3a763 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.40e-05 | 194 | 195 | 7 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.48e-05 | 195 | 195 | 7 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.48e-05 | 195 | 195 | 7 | e7230a849ea31e6eef9bc6f5468938499450582d | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l14|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.55e-05 | 132 | 195 | 6 | 14a512f433315892bf0326419f23d0d5919d01ec | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 2.56e-05 | 196 | 195 | 7 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-05 | 196 | 195 | 7 | b8f89a50114932c08fc5daac4b549adfe9df8e66 | |
| ToppCell | (7)_Epithelial-I_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.56e-05 | 196 | 195 | 7 | 150554fa06868d29b0608189862eef6505ba757f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-05 | 196 | 195 | 7 | 145fcf73deba9638b391a1af6c39fa205dc9829f | |
| ToppCell | COVID-19-lung-Capillary_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.56e-05 | 196 | 195 | 7 | ac28e9be288af6f00a841aea4ce4b99aed6b4505 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-05 | 196 | 195 | 7 | d0ff1082898d2db47c88d2678466514e9e9193d3 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 2.64e-05 | 197 | 195 | 7 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.64e-05 | 197 | 195 | 7 | 0f467ef58f0c4dcc00b34b7b9639e03fb3ebe780 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 2.64e-05 | 197 | 195 | 7 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.73e-05 | 198 | 195 | 7 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-05 | 199 | 195 | 7 | 1d5a3366474c17e3df0ba5cf11b586655529e9bd | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.91e-05 | 200 | 195 | 7 | ed093626a9cac7531a2bf02f6e345c5e84b8c060 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.91e-05 | 200 | 195 | 7 | 7c2d499af60654b7b28f172ac2c914ad49fb74b4 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial-Astrocyte|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 2.91e-05 | 200 | 195 | 7 | b9bd6c4381c92bfc1bfff9aa778a62a41d08f1ef | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW12-Stem_cells|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 2.91e-05 | 200 | 195 | 7 | 4a57d6ba1531ce4e263daccd5de487977e6a1fdd | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW12-Stem_cells-Stem_cells|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 2.91e-05 | 200 | 195 | 7 | b706526b9c3485889a31253a1ffd017ad3f3fddc | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_2-C1R-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.91e-05 | 200 | 195 | 7 | 891a80cbde575f81f3466217175f41e1d4f66d5e | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_2-C1R|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.91e-05 | 200 | 195 | 7 | c761d1742653a83e69e4c03d6e10e5e53f28bebb | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_2-C1R--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.91e-05 | 200 | 195 | 7 | dcbc91ed3351bafd72cf71d7025cbbdc8361d9b9 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.22e-05 | 159 | 195 | 6 | 8680b054622f573a82b1625fb93c2d5db81d1034 | |
| ToppCell | AT1_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 8.01e-05 | 162 | 195 | 6 | ae2ba4f21f6f6c512006fa531d670b88be7c04c9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.86e-05 | 165 | 195 | 6 | 88681101d7cf60b99b8ace5d8c0944323b937306 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.16e-05 | 166 | 195 | 6 | 13027ae342994db4540e64eb910df1f42b160931 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.16e-05 | 166 | 195 | 6 | b21e45bd43f26149b9cd6e45c19241c82d54fb2f | |
| ToppCell | facs-Trachea-nan-18m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.47e-05 | 167 | 195 | 6 | 7b1fd19946cee67dae68f0f0d98420abcd532482 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 9.79e-05 | 168 | 195 | 6 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-8|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 9.79e-05 | 168 | 195 | 6 | 00646601548b0fee42ae16bfa5e93603bc7c5129 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 1.04e-04 | 170 | 195 | 6 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.08e-04 | 171 | 195 | 6 | 5efd15300f865ebf651e0888265cbd717bc3b9d3 | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.11e-04 | 172 | 195 | 6 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.19e-04 | 174 | 195 | 6 | edf839d79ac58921f4e788f3b2cb2ae0d6af4b9e | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 1.19e-04 | 174 | 195 | 6 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.19e-04 | 174 | 195 | 6 | 65539f69100db0b7d90b1b39ee15ab8281f86461 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.22e-04 | 175 | 195 | 6 | 96219e58dcb327fd27190be78193e7a0d611e62b | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.22e-04 | 175 | 195 | 6 | cb974fbebe8cb58c7d3f7defabb4e056f2fee5fa | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-capillary_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.30e-04 | 177 | 195 | 6 | fdf2af00fc971f0cd3915e1416e4a256458d6ea8 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.30e-04 | 177 | 195 | 6 | 12f8627124acbf436e75681ff1ce429ff5e3f256 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 179 | 195 | 6 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.43e-04 | 180 | 195 | 6 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 181 | 195 | 6 | fcc94f04dae98b817ec06b282d2e887804d37ae5 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.52e-04 | 182 | 195 | 6 | 63b41b538b26bc899558807fd035e543611f8c52 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.52e-04 | 182 | 195 | 6 | 215c303df42f13597b2c7a95cb157c6bc7aca9a1 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.52e-04 | 182 | 195 | 6 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-04 | 183 | 195 | 6 | dc19857b66dcadbf7c87de91f7b1f4e8ef2857ed | |
| ToppCell | PND07-28-samps-Epithelial-Alveolar_epithelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.56e-04 | 183 | 195 | 6 | 23e55f88a802a9299d2773f9394970e86e8bbfaa | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-04 | 183 | 195 | 6 | 4759560e5b4f4e5a00e5f933e3451a27c7c4aefe | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.56e-04 | 183 | 195 | 6 | 3ef9ac1ae13b6172f9121ab1c129ecaa0fef460f | |
| ToppCell | PND07-28-samps-Epithelial-Alveolar_epithelial-AT2|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.56e-04 | 183 | 195 | 6 | 0a69e22750dd8b66ab988cf36d0dd2b59e2f7d26 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.56e-04 | 183 | 195 | 6 | c1297d8eddfc7132e84ceef14f01b6281f9d0f6a | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.61e-04 | 184 | 195 | 6 | cb15d6bae52c5ec251c2235859dc7e65f630ae23 | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; PC3; HT_HG-U133A | ARHGAP32 DAG1 ITGA6 GLI3 SVIL TMEM131L PLXNA1 TTC28 APC SHROOM2 HDAC7 EPN2 | 1.58e-08 | 177 | 178 | 12 | 4652_DN |
| Drug | BM-I | 1.70e-06 | 12 | 178 | 4 | CID016058649 | |
| Drug | PHA-00767505E [723337-45-9]; Down 200; 10uM; PC3; HT_HG-U133A | CNNM2 IRF2 FBXO22 ABCD4 SIK2 CLEC16A RASAL2 PTPN21 RUNX1 CDC14A | 3.62e-06 | 197 | 178 | 10 | 6545_DN |
| Drug | Paclitaxel [33069-62-4]; Up 200; 4.6uM; MCF7; HT_HG-U133A | 2.39e-05 | 195 | 178 | 9 | 1542_UP | |
| Drug | Nalidixic acid sodium salt hydrate; Down 200; 14.6uM; HL60; HT_HG-U133A | 2.39e-05 | 195 | 178 | 9 | 2336_DN | |
| Drug | Nifedipine [21829-25-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 2.49e-05 | 196 | 178 | 9 | 1692_DN | |
| Drug | Mecamylamine hydrochloride [826-39-1]; Up 200; 19.6uM; PC3; HT_HG-U133A | 2.49e-05 | 196 | 178 | 9 | 7263_UP | |
| Drug | Foliosidine [2520-38-9]; Down 200; 13uM; PC3; HT_HG-U133A | 2.59e-05 | 197 | 178 | 9 | 4295_DN | |
| Drug | Orlistat; Down 200; 10uM; PC3; HT_HG-U133A | 2.70e-05 | 198 | 178 | 9 | 6388_DN | |
| Drug | topiramate; Up 200; 3uM; MCF7; HT_HG-U133A_EA | 2.70e-05 | 198 | 178 | 9 | 915_UP | |
| Drug | mitoxantrone | 2.95e-05 | 154 | 178 | 8 | CID000004212 | |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 4.41e-26 | 46 | 191 | 17 | DOID:5426 (implicated_via_orthology) |
| Disease | congenital heart disease (implicated_via_orthology) | USP17L21 KMT2B USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 2.27e-24 | 69 | 191 | 18 | DOID:1682 (implicated_via_orthology) |
| Disease | macrophage inflammatory protein 1b measurement | 3.08e-05 | 136 | 191 | 7 | EFO_0008219 | |
| Disease | platelet crit | EPO MYO9B NHSL2 DACH1 DAG1 SVIL TMEM131L RASAL2 TTC28 NOC3L ABCC5 MARCHF7 RUNX1 HDAC7 CCND3 MPHOSPH9 CBX8 | 1.64e-04 | 952 | 191 | 17 | EFO_0007985 |
| Disease | mean platelet volume | EPO ARHGAP32 MYO9B KIF1B BCORL1 ITGA6 MCM3 SVIL TMEM131L SLC12A6 PCDHGC4 TTC28 FBRSL1 ABCC5 RUNX1 HDAC7 OPRD1 | 3.65e-04 | 1020 | 191 | 17 | EFO_0004584 |
| Disease | cortical surface area measurement | RELN CNNM2 MYO9B ZC3H13 KIF1B CUL9 NCKAP5 STOX1 PLEKHG1 NUAK1 ARHGAP31 GLI3 MTMR2 WWC1 PDZRN4 TICRR APC TRIOBP MARCHF7 MPHOSPH9 | 4.82e-04 | 1345 | 191 | 20 | EFO_0010736 |
| Disease | Liver carcinoma | 4.99e-04 | 507 | 191 | 11 | C2239176 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 6.25e-04 | 60 | 191 | 4 | C4722327 | |
| Disease | ganglion cell inner plexiform layer thickness measurement | 7.76e-04 | 28 | 191 | 3 | EFO_0600005 | |
| Disease | sclerosing cholangitis | 8.96e-04 | 66 | 191 | 4 | EFO_0004268 | |
| Disease | Eczema | 9.78e-04 | 310 | 191 | 8 | HP_0000964 | |
| Disease | adult onset asthma | 1.04e-03 | 118 | 191 | 5 | EFO_1002011 | |
| Disease | Prostate cancer, familial | 1.06e-03 | 69 | 191 | 4 | C2931456 | |
| Disease | lateral ventricle volume measurement | 1.26e-03 | 33 | 191 | 3 | EFO_0008487 | |
| Disease | clopidogrel metabolite measurement | 1.26e-03 | 33 | 191 | 3 | EFO_0007966 | |
| Disease | Lynch Syndrome | 1.46e-03 | 9 | 191 | 2 | C4552100 | |
| Disease | Gastrointestinal Hemorrhage | 1.46e-03 | 9 | 191 | 2 | C0017181 | |
| Disease | BMI-adjusted waist-hip ratio, adult onset asthma | 1.46e-03 | 9 | 191 | 2 | EFO_0007788, EFO_1002011 | |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 1.46e-03 | 9 | 191 | 2 | DOID:0050338 (implicated_via_orthology) | |
| Disease | allergic disease | 1.52e-03 | 258 | 191 | 7 | MONDO_0005271 | |
| Disease | refractive error, age at onset, Myopia | 1.66e-03 | 193 | 191 | 6 | EFO_0004847, HP_0000545, MONDO_0004892 | |
| Disease | age of onset of asthma | 1.75e-03 | 79 | 191 | 4 | OBA_2001001 | |
| Disease | age at onset, multiple sclerosis | 1.81e-03 | 10 | 191 | 2 | EFO_0004847, MONDO_0005301 | |
| Disease | nucleus accumbens volume change measurement | 2.21e-03 | 11 | 191 | 2 | EFO_0021493 | |
| Disease | mean corpuscular hemoglobin concentration | CNNM2 MYO9B DAG1 MDM2 MTMR2 TICRR CYP26B1 TTC28 CLASP1 FBRSL1 ABCC5 RUNX1 HDAC7 OPRD1 IGDCC4 CCND3 | 2.33e-03 | 1105 | 191 | 16 | EFO_0004528 |
| Disease | colorectal cancer, endometrial neoplasm | 2.55e-03 | 42 | 191 | 3 | EFO_0004230, MONDO_0005575 | |
| Disease | waist-hip ratio | MYO9B DAG1 CUL9 WDR38 SSC5D NRXN3 GLI3 CLEC16A SHISA6 PDZRN4 IPPK SEC16B TTC28 RUNX1 SIPA1 PPP1R3A MEGF8 | 2.67e-03 | 1226 | 191 | 17 | EFO_0004343 |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 3.10e-03 | 13 | 191 | 2 | C1846647 | |
| Disease | receptive language perception, parental genotype effect measurement | 3.60e-03 | 14 | 191 | 2 | EFO_0005686, EFO_0005939 | |
| Disease | reaction time measurement | NCKAP5 CCDC88B POM121 PDZRN4 TTC28 FBRSL1 MUC19 APC POLI TSHZ1 RFPL3 | 3.90e-03 | 658 | 191 | 11 | EFO_0008393 |
| Disease | eosinophil percentage of granulocytes | 4.31e-03 | 234 | 191 | 6 | EFO_0007996 | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 4.43e-03 | 51 | 191 | 3 | cv:CN043650 | |
| Disease | developmental dysplasia of the hip | 4.71e-03 | 16 | 191 | 2 | EFO_1000648 | |
| Disease | Polyposis, Adenomatous Intestinal | 4.71e-03 | 16 | 191 | 2 | C2713442 | |
| Disease | Familial Intestinal Polyposis | 4.71e-03 | 16 | 191 | 2 | C2713443 | |
| Disease | Diuretic use measurement | 4.97e-03 | 169 | 191 | 5 | EFO_0009928 | |
| Disease | Adenomatous Polyposis Coli | 5.32e-03 | 17 | 191 | 2 | C0032580 | |
| Disease | Rheumatoid Arthritis | 5.61e-03 | 174 | 191 | 5 | C0003873 | |
| Disease | response to calcium channel blocker | 5.75e-03 | 56 | 191 | 3 | EFO_0007767 | |
| Disease | Colorectal Carcinoma | GLI3 MKI67 ABCD4 PZP RASAL2 PDZRN4 APC ABCC5 CDC14A EIF4G1 TNS4 | 6.26e-03 | 702 | 191 | 11 | C0009402 |
| Disease | Agents acting on the renin-angiotensin system use measurement | 6.37e-03 | 335 | 191 | 7 | EFO_0009931 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SSSERQTADAPARLT | 686 | Q9Y2J4 | |
| ERSRELSAESFLPTA | 251 | Q9HCM7 | |
| LSVREDSVPTTASFS | 11 | P30411 | |
| LRESLREASQTSSSP | 251 | P30281 | |
| LSSRFPVGRSSESFS | 1396 | A6NC98 | |
| PSTLARAFSTSVLSD | 1036 | Q8IZF6 | |
| SARFLSRSIPSLQSE | 576 | Q9UNH5 | |
| PSARVAVLFTRSEDA | 261 | Q14416 | |
| PAQSRTVTSSFLIRD | 86 | Q9BZE3 | |
| SSFRDFIPVVLSTRT | 1211 | Q5H9F3 | |
| RSASSEEASESPTAR | 1466 | Q5H9F3 | |
| SFDSRGSRPTTETEF | 166 | Q9UKB5 | |
| SELRSAFSAARTTPL | 26 | Q9BXJ3 | |
| ELAESSPAASFLSSR | 441 | Q9BQC3 | |
| ERLDRTASPSTSSID | 376 | Q96P50 | |
| EVFRSSRLSSDATVL | 166 | Q63HQ0 | |
| AFLLERVSISAPSSD | 386 | O14678 | |
| ESPELSRASSATFRP | 596 | Q9Y4F5 | |
| ASAAEAVRSSTSRPR | 216 | Q7Z5J1 | |
| VSSSPARTESSSDRI | 516 | Q9UI36 | |
| SASVLSRPEASRTGE | 26 | P48201 | |
| IFASTDSRRTSPVGS | 146 | P55064 | |
| PEALSRTRASTARFV | 341 | Q8TDY8 | |
| VSFTLPRISASSEVA | 86 | P20742 | |
| TAESCRSTPLTVDRS | 741 | Q6ZMN7 | |
| VTLFRSPDSVDRVLS | 986 | Q9H0J4 | |
| SSRSRFAFSVSVLDL | 426 | Q9H8X2 | |
| SSSSRPDRETRASVI | 321 | P14316 | |
| ADDSRFSILAPSFTS | 136 | O75747 | |
| TFRSAFRTSEGIVPT | 231 | Q9HCM3 | |
| DASRLIFRLSSSSGV | 501 | Q15124 | |
| IAASYPVSRSRAASS | 236 | Q96PE2 | |
| RGSSVDPRSTFVLSN | 11 | Q8NEZ5 | |
| RTISLPTSESLVSFR | 2181 | Q8WXI7 | |
| ESTRARTEPNSFLTI | 4001 | Q8WXI7 | |
| RLRETSTSQESSFPT | 5191 | Q8WXI7 | |
| SSRTSISDLDRPTIA | 5526 | Q8WXI7 | |
| TSVLTSTPAFLETRR | 7806 | Q8WXI7 | |
| FTVEATARVTPRSSD | 196 | O60500 | |
| SASEPRAASRVSAVS | 61 | Q5XUX1 | |
| DITDAPVSSLSRRRS | 1176 | Q15058 | |
| DPISTDASRRSSEAS | 896 | P10071 | |
| SSSLKERSRPFTVAA | 581 | Q9UHB6 | |
| ERSRPFTVAASFQST | 586 | Q9UHB6 | |
| SESTTCLFRTRPLDA | 706 | Q8IX03 | |
| DRAARATSPRVSSEL | 251 | O95208 | |
| NERLADRTPSPTFST | 901 | O60333 | |
| ARPASAALRRSFSTS | 6 | P40926 | |
| VELASTSRFELATRT | 456 | Q9NR63 | |
| RSVSDSSVPRRDSLS | 4366 | Q2LD37 | |
| PDPRDIFSERSSLSS | 431 | Q6ZUT3 | |
| RSFRVTIPTDLIASS | 76 | Q14118 | |
| RVSSDLPTSVRSSVE | 3201 | Q5CZC0 | |
| TSATDVRPLSTRDST | 81 | Q96I76 | |
| SPARVTALRFNSSSL | 751 | Q9UIW2 | |
| SRYESLLRTASSPDS | 1596 | P51805 | |
| SSRESVTTRPLAEGS | 2146 | Q7Z5P9 | |
| EESRTTRPSAGITAT | 6106 | Q7Z5P9 | |
| RTTRSEAPGEATTLT | 6741 | Q7Z5P9 | |
| ASSRRVSSSSELDLP | 1061 | Q92614 | |
| STPSDTSSEDGVRRI | 196 | Q9H5P4 | |
| ISVNSRRTPFTASGE | 556 | Q9Y4C0 | |
| PSTRSDRLAVGFSTT | 1111 | Q9Y4C0 | |
| PSTARFSVRVNSTEL | 411 | Q7Z7M0 | |
| VRPSRANTLATSDVS | 661 | Q99550 | |
| DRNTSFRLPSLRSTD | 61 | Q9UJF2 | |
| STSADNFSPDLRVLR | 51 | Q13614 | |
| DPISTDASRRSSEAS | 856 | P10070 | |
| TSRDAARFPIIASCT | 71 | Q8TCT9 | |
| SASETESVPSRSRRG | 911 | Q9UMN6 | |
| SVLLSPSAVESRRNS | 371 | Q9ULI3 | |
| VGSLSDSVTIFRSRP | 491 | P23229 | |
| ARRVSRSSFSSDPDE | 121 | P46013 | |
| SSSSEFPGRTFSDVR | 696 | Q32M88 | |
| EPRNRDVSASSFISL | 496 | Q9Y5F7 | |
| VSRGTAPSDNRVTSF | 61 | Q9UNZ2 | |
| RRPRSSSDALSASFN | 726 | A7KAX9 | |
| ESPSLESRSTAVTRT | 271 | Q8NDX5 | |
| TDSSSADPVRLEFSR | 2031 | P78509 | |
| ISSRSPESLAFLSDR | 666 | Q5TIA1 | |
| DPSSFSRAREATARE | 341 | P41143 | |
| TLSASAAEVAPRAVS | 656 | Q16825 | |
| TPSSGTRRVSFADSF | 56 | Q16821 | |
| SSSAELDRSRPAVSV | 76 | Q8TCG2 | |
| DTARTSPVTARTLET | 606 | P25205 | |
| RFSRSAIPEQIISST | 281 | Q96HA1 | |
| FTSPESSVTAAPRAR | 41 | P98173 | |
| ISSSLRSRVFLPTND | 126 | Q5VYJ5 | |
| TVRLASETEARFTSV | 1146 | O15440 | |
| LPARTVTADSRTISD | 816 | Q6WRI0 | |
| RRADSARTTSTFKAP | 451 | Q9UHR4 | |
| TSTSSTCRAEAPRDR | 136 | Q9HC52 | |
| SIARTVDSRLFSFSE | 836 | Q8IZD9 | |
| EDFISSTISTTPRAF | 301 | P16070 | |
| LSVDRLERVSSTSPS | 331 | P32246 | |
| TILSPTASREDRALT | 31 | H7BZ55 | |
| ARSVERASTPYSIDS | 171 | Q9UPW0 | |
| ASAATESPFAQSRRI | 836 | Q5TH69 | |
| TSSQEASSASEPRRA | 1001 | O75128 | |
| AAAALAPSATRTRRS | 31 | Q7Z7K6 | |
| AASAAPLRTITADTF | 151 | P01588 | |
| ELSASASSSTPRRAA | 471 | A1A5D9 | |
| SDAASEAARPATSTL | 1106 | Q04637 | |
| EAARPATSTLNRFSA | 1111 | Q04637 | |
| RDESSRIPTSDTSSR | 406 | Q9H992 | |
| SSFLREIRTIASDPD | 316 | O75578 | |
| ETSRNPLSRAASFAS | 1406 | Q8IWT3 | |
| EFTPQSILRSTLRST | 1196 | Q8WYP5 | |
| SQARVLSSSETPART | 501 | Q8WUI4 | |
| VLSETFRSSDPATRQ | 141 | P51530 | |
| RVSSLRFLQAPSASS | 166 | Q9NYF3 | |
| STRTRESPLDTTNFS | 496 | Q9UNA4 | |
| SRVRFSSRESVPETS | 41 | Q9UHW9 | |
| ESSSSRAVSPFAKIR | 1061 | Q9Y2H2 | |
| EESSSALTRALRAEF | 826 | Q9UPN4 | |
| SVRAFATAFLSSEPR | 101 | Q6UX07 | |
| TSLIPATFTAASRDA | 576 | A6NNC1 | |
| RVSFLTRDLSSSEPV | 106 | Q8WTT2 | |
| SSRLSTAPDLTAFSD | 291 | Q01196 | |
| SVFTAASTERAPVTL | 381 | Q08AM6 | |
| RDGSRLSASTVPLTF | 221 | O75677 | |
| RFPFVRERSDSTGSS | 141 | Q96TC7 | |
| RATEALQTFRPAASS | 391 | Q7Z4K8 | |
| ADDSFRTRNASSVPS | 816 | Q6NUP7 | |
| EDALVLRSARTSSPA | 351 | Q5SQN1 | |
| SFSGRDSSFTEVPRS | 231 | O95425 | |
| SRDISIVFTPDFTSS | 811 | A2VDJ0 | |
| TFPVSISRNSTEDRF | 306 | Q14C87 | |
| RVLTSAFSRATRDPF | 466 | Q96KG9 | |
| PAAAFERSLSQRSSE | 66 | Q8NDG6 | |
| VPRVSTESFSSRTVT | 751 | O14513 | |
| ASRFRERSLSVPTDS | 491 | Q5HYW2 | |
| SQEDRTRASTLSPDF | 141 | Q8WZ73 | |
| SLPARVSVRFSGDTT | 11 | P49821 | |
| PSTRSDRLAVGFSTT | 106 | Q9HDB5 | |
| PLDESRASITSVTSF | 1311 | Q9H6K5 | |
| RASITSVTSFSPDDV | 1316 | Q9H6K5 | |
| PSTSSRRRAISETEE | 156 | Q00987 | |
| RATETSRPSLSETLF | 151 | Q92835 | |
| SPVSFREGRRASDTS | 576 | Q9H0K1 | |
| EEASRPAATSTRLFT | 76 | Q96FS4 | |
| SRLQASLSSSDVRFP | 406 | Q13796 | |
| ERTAFPEQSLSRAIS | 411 | Q6ZSJ9 | |
| PSRSRLRDSASSAED | 46 | Q8IZD0 | |
| LSRSYSRPSSVISDD | 561 | O60285 | |
| PASRSEFVERSSCRA | 461 | Q5T8A7 | |
| AALTTEASRRPTSEF | 666 | A1L4H1 | |
| RVRSAFAAPSTDSDQ | 501 | B9A6J9 | |
| VCFSESSLPTGDRTR | 161 | Q9H0A9 | |
| TAQAASTREIPRASS | 266 | Q9H2D6 | |
| FADPEVLRRLTSSVS | 166 | Q8IWZ3 | |
| LEESASFESLSPSSR | 2456 | P25054 | |
| RVTFVDPRDLTSAAS | 606 | Q8IUL8 | |
| TSAASAPSDLRFVDS | 616 | Q8IUL8 | |
| RGSSDPTVQRSVFAS | 861 | Q2KHT3 | |
| TSRESSRDTSPARGF | 756 | Q7Z460 | |
| EASRESSRDTSPVRS | 531 | O75122 | |
| SLSRSDRIDAVTPTL | 761 | Q9H8M5 | |
| RSASLSYPDRTDVST | 661 | Q6P4Q7 | |
| RVRSAFAAPSTDSDQ | 501 | A6NDS4 | |
| RVRSAFAAPSTDSDQ | 501 | P0C7X1 | |
| TVFRARFSSITDTDI | 146 | O95985 | |
| TSSRPDAAFAEIQRT | 21 | A6NCW0 | |
| SARTEERETSRAFPS | 181 | Q6P1L6 | |
| TAVADSPRDTASLFS | 436 | Q7Z2Z1 | |
| SPRDTASLFSDVVDS | 441 | Q7Z2Z1 | |
| STVEDSPFSRAFSRR | 1876 | Q7Z2Z1 | |
| TSSRPDAAFAEIQRT | 21 | A6NCW7 | |
| RVRSAFAAPSTDSDQ | 501 | A6NER0 | |
| LSRDVPRETRSSSES | 186 | Q8IZW8 | |
| PRETRSSSESLIFSG | 191 | Q8IZW8 | |
| ASFSDRTPSACRLVD | 646 | Q6ZVD7 | |
| SITVDSGFNSPRTRE | 851 | Q9P2F5 | |
| PASNREAATASTSRA | 776 | Q96HA7 | |
| TSSRPDAAFAEIQRT | 21 | D6R9N7 | |
| TSSRPDAAFAEIQRT | 21 | A8MUK1 | |
| TSSRPDAAFAEIQRT | 21 | D6R901 | |
| TSSRPDAAFAEIQRT | 21 | D6RCP7 | |
| RVRSAFAAPSTDSDQ | 501 | A0A087X179 | |
| SDRFSAERPEGSIST | 81 | A0A0K0K1E9 | |
| RNSAPVSVSAVRTSF | 1176 | Q2M1Z3 | |
| RDGSRLSASTVPLTF | 221 | O75679 | |
| TSSRPDAAFAEIQRT | 21 | Q7RTZ2 | |
| VRAEATTRSRESSPS | 986 | Q96JH7 | |
| SQASFRISVPSSESR | 501 | Q9ULM0 | |
| AARPRSISESSASSA | 861 | Q96JE7 | |
| EAEASRSLESRSSRP | 101 | A0A2R8Y7D0 | |
| TFTLERVSPSTSDLA | 691 | Q6ZN44 | |
| TSSRPDAAFAEIQRT | 21 | C9JPN9 | |
| FRASETSAFSRPVLS | 2206 | Q96AY4 | |
| RSVETVSFSPDSRQL | 106 | Q5JTN6 | |
| RATFVSSVRPESSRL | 636 | Q4KMQ1 | |
| TSSRPDAAFAEIQRT | 21 | Q0WX57 | |
| PTFVRELRSRTFDSS | 121 | Q9UPP1 | |
| RVRSAFAAPSTDSDQ | 501 | A0A087WVF3 | |
| STPELSRDVGRSVST | 876 | Q9ULL1 | |
| TSSRPDAAFAEIQRT | 21 | Q6QN14 | |
| DVRESTAFSRSLLPV | 146 | Q01831 | |
| TSSRPDAAFAEIQRT | 21 | D6RA61 | |
| RTRRAASVAAATTSP | 191 | Q9Y2D9 | |
| RVRSAFAAPSTDSDQ | 501 | Q6DHY5 | |
| RVRSAFAAPSTDSDQ | 501 | Q8IZP1 | |
| TSSRPDAAFAEIQRT | 21 | C9J2P7 | |
| TSSRPDAAFAEIQRT | 21 | D6RBQ6 | |
| RFSRSAIPEQIISST | 16 | Q6PJE2 | |
| AVAASFSPRSVSIRR | 206 | Q04912 | |
| SATSRKSVREAASAP | 221 | P50607 | |
| RVRSAFAAPSTDSDQ | 501 | A0A087X1G2 | |
| TSSRPDAAFAEIQRT | 21 | D6RBM5 | |
| VSSVADSVASPLRES | 821 | Q6ZSZ6 | |
| SRSNTEDFPLRLESA | 86 | A0A0J9YX75 | |
| TSSRPDAAFAEIQRT | 21 | Q6R6M4 | |
| TAVSSNRDPRTTAVS | 376 | Q8N7P7 | |
| ISDSTSRRPSVFERL | 16 | Q5T200 | |
| RVRSAFAAPSTDSDQ | 501 | A0A087WXS9 | |
| RVRSAFAAPSTDSDQ | 501 | Q6IPX1 | |
| SGRFSAERPERSVST | 81 | A0A1B0GX95 | |
| TSSRPDAAFAEIQRT | 21 | D6RJB6 | |
| SRSTTEDFPLRLLSA | 86 | A0A0K0K1A5 | |
| TSSRPDAAFAEIQRT | 21 | C9JJH3 | |
| TSSRPDAAFAEIQRT | 21 | C9JVI0 | |
| SAITPAAGRSRFSSV | 21 | O95678 | |
| ASPASVRSLGRFSSV | 326 | Q9P206 | |
| TGAALTPTEERRTSF | 1341 | Q13459 |